title: In brief: Nitisinone (Orfadin) for hereditary tyrosinemia.
mesh_terms: D015111:4-Hydroxyphenylpyruvate Dioxygenase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000284:Administration, Oral; D002214:Capsules; D003512:Cyclohexanones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009579:Nitrobenzoates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019999:Pharmaceutical Solutions; D016896:Treatment Outcome; D020176:Tyrosinemias / Q000175:diagnosis / Q000188:drug therapy* / Q000201:enzymology
chemical_list: D002214:Capsules; D003512:Cyclohexanones; D004791:Enzyme Inhibitors; D009579:Nitrobenzoates; D019999:Pharmaceutical Solutions; D015111:4-Hydroxyphenylpyruvate Dioxygenase; C077073:nitisinone